Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England

The emergence of the COVID-19 vaccination has been critical in changing the course of the COVID-19 pandemic. To ensure protection remains high in vulnerable groups booster vaccinations in the UK have been targeted based on age and clinical vulnerabilities. We undertook a national retrospective cohor...

Bibliográfalaš dieđut
Váldodahkkit:	Ward, IL, Robertson, C, Agrawal, U, Patterson, L, Bradley, DT, Shi, T, de Lusignan, S, Hobbs, FDR, Sheikh, A, Nafilyan, V
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Springer Nature 2024

Geahča maid

Risk of COVID-19 death in adults who received booster COVID-19 vaccinations in England
Dahkki: Isobel L. Ward, et al.
Almmustuhtton: (2024-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
Dahkki: Bedston, S, et al.
Almmustuhtton: (2023)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Dahkki: Gu, X, et al.
Almmustuhtton: (2024)

Variation in COVID-19 booster uptake in England: An ecological study.
Dahkki: Greg Dropkin
Almmustuhtton: (2022-01-01)

Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and WalesResearch in context
Dahkki: Stuart Bedston, et al.
Almmustuhtton: (2024-02-01)

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Dahkki: Piotr Rzymski, et al.
Almmustuhtton: (2021-11-01)

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales
Dahkki: Agrawal, U, et al.
Almmustuhtton: (2022)

COVID-19 Vaccine Booster: To Boost or Not to Boost
Dahkki: Rahul Shekhar, et al.
Almmustuhtton: (2021-10-01)

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru
Dahkki: Guido Bendezu-Quispe, et al.
Almmustuhtton: (2022-07-01)

Excess mortality from COVID-19 in an English sentinel network population
Dahkki: Joy, M, et al.
Almmustuhtton: (2020)

Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine roll-out.
Dahkki: Matt Bosworth, et al.
Almmustuhtton: (2022-08-01)

The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S.
Dahkki: Matt Motta
Almmustuhtton: (2022-10-01)

Waning of first and second dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales
Dahkki: Kerr, S, et al.
Almmustuhtton: (2022)

COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Dahkki: Xinchun Gu, et al.
Almmustuhtton: (2024-08-01)

Predicting the intention to receive the COVID-19 booster vaccine based on the health belief model
Dahkki: Milja Ventonen, et al.
Almmustuhtton: (2024-06-01)

Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy
Dahkki: Lucio Folcarelli, et al.
Almmustuhtton: (2022-01-01)

Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review
Dahkki: Yam B. Limbu, et al.
Almmustuhtton: (2023-03-01)

Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia
Dahkki: Li Ping Wong, et al.
Almmustuhtton: (2022-11-01)

Covid-19 booster shot advisable
Dahkki: The Star
Almmustuhtton: (2021)

Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study
Dahkki: Tsang, RSM, et al.
Almmustuhtton: (2023)

Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
Dahkki: Vahé Nafilyan, et al.
Almmustuhtton: (2023-03-01)

Longitudinal changes in proportionate mortality due to COVID-19 by occupation in England and Wales
Dahkki: Mark Cherrie, et al.
Almmustuhtton: (2022-11-01)

Factors Influencing the Healthcare Workers’ Willingness to Receive the COVID-19 Booster Dose in Tuscany (Italy)
Dahkki: Giovanni Guarducci, et al.
Almmustuhtton: (2023-11-01)

Drivers of the Intention to Receive a COVID-19 Booster Vaccine: Insights from the UK and Australia
Dahkki: Kirsten Barnes, et al.
Almmustuhtton: (2022-10-01)

Bivalent second booster dose of the COVID-19 vaccine: Eligible populations’ reasons for receiving in Italy
Dahkki: Giorgia Della Polla, et al.
Almmustuhtton: (2023-01-01)

Factors Associated With Marshallese and Hispanic Adults’ Willingness to Receive a COVID-19 Booster Dose
Dahkki: Rachel S. Purvis, et al.
Almmustuhtton: (2023-05-01)

Lessons from the English primary care sentinel network's response to the COVID-19 pandemic
Dahkki: de Lusignan, S, et al.
Almmustuhtton: (2023)

Adverse events after first and second doses of COVID-19 vaccination in England: a national vaccine surveillance platform self-controlled case series study
Dahkki: Tsang, RS, et al.
Almmustuhtton: (2023)

Estimating the effectiveness of first dose of COVID-19 vaccine against mortality in England: a quasi-experimental study
Dahkki: Bermingham, C, et al.
Almmustuhtton: (2022)

Evaluation of COVID-19 Booster Vaccine Effectiveness
Dahkki: Bingqian Qu, et al.
Almmustuhtton: (2025-01-01)

Booster Dose of COVID 19 and Ethical Issues
Dahkki: Adeela Shahid
Almmustuhtton: (2021-12-01)

Booster Vaccination Strategies for “Living With COVID-19”
Dahkki: Jung Eun Kim, et al.
Almmustuhtton: (2022-06-01)

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
Dahkki: Freja Cordelia Møller Kirsebom, et al.
Almmustuhtton: (2022-12-01)

Evaluation of the Efficacy of COVID-19 Booster Vaccinations in Healthcare Personnel
Dahkki: Chung-Jong Kim, et al.
Almmustuhtton: (2022-10-01)

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel
Dahkki: Nicholas M. Mohr, et al.
Almmustuhtton: (2023-12-01)

Healthcare workers’ willingness to receive COVID-19 booster dose and associated factors in the Democratic Republic of the Congo
Dahkki: Bertin Mindje Kolomba, et al.
Almmustuhtton: (2024-12-01)

Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine
Dahkki: Piotr Rzymski, et al.
Almmustuhtton: (2022-05-01)

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
Dahkki: Walid Al-Qerem, et al.
Almmustuhtton: (2022-03-01)

The association between adverse events of COVID-19 vaccination and anxiety and willingness to receive a booster dose
Dahkki: Liling Chen, et al.
Almmustuhtton: (2023-01-01)

COVID-19 booster vaccination uptake and infection breakthrough amongst health care workers in Wales: a national prospective cohort study
Dahkki: Bedston, S, et al.
Almmustuhtton: (2023)